Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade

Document Details

Document Type
Pub Defense Publication
Publication Date
Apr 01, 2018
Source ID
10.1016/j.cell.2018.03.026

Entities

People

  • Alexander Meissner
  • Alexandra Snyder
  • Andreas Gnirke
  • Arman Mohammad
  • Bastian Schilling
  • Catherine J Wu
  • Christina Galonska
  • Christine G. Lian
  • Clyde Bango
  • Daniel Gusenleitner
  • Derin B Keskin
  • Diana Miao
  • Dirk Schadendorf
  • Donna Neuberg
  • Eliezer M. Van Allen
  • F Stephen Hodi
  • George F. Murphy
  • Jedd D. Wolchok
  • Jeffrey S. Weber
  • Kendell Clement
  • Levi A. Garraway
  • Mehrtash Babadi
  • Nir Hacohen
  • Patrick C Lee
  • Patrick R. Potts
  • Pavan Bachireddy
  • Qian Zhan
  • Rupert Langer
  • Sachet A Shukla
  • Taha Merghoub
  • Ying Huang
  • Zachary J. Cartun

Organizations

  • Blavatnik Family Foundation
  • Bristol-Myers Squibb
  • Damon Runyon Cancer Research Foundation
  • Dana Farber Harvard Cancer Center
  • EMD Serono (United States)
  • Hoffmann-La Roche
  • Howard Hughes Medical Institute
  • MSD (United Kingdom)
  • National Cancer Institute
  • National Heart, Lung, and Blood Institute
  • National Institutes of Health
  • New York Stem Cell Foundation
  • Novartis
  • The Starr Foundation
  • United States Department of Defense